Omicron, surely that’s enough

What have the scientific, pharmaceutical, and medical communities done to stifle SARS-CoV-2 infections? There are currently 18 advanced trials of different vaccines, 64 possible new treatments, and 23 potential or approved anti-viral drugs.

The mRNA vaccines from Pfizer and Moderna provide robust protection. (The mRNA technology is being expanded to HIV, malaria, and other diseases for which conventional vaccines have failed.) mRNA vaccines are expensive and need to be shipped frozen. Lower income countries require an effective vaccine that is inexpensive, survives at higher temperature and can be made locally.  Corbevax, created at Baylor College of Medicine, fits these criteria and is currently being made in hundreds of millions of doses in India. Other vaccines (Novovax) produce antibodies to viral proteins in addition to the Spike protein. The Novovax vaccine contains no genetic material.

Beyond vaccines there are 64 new treatments in development that block or slow infection or some of its consequences, like inflammation. Inflammation makes blood vessels leaky; defensive cells, which rush to the site of infection, squeeze out of the circulation, and infiltrate the lungs. They fill air sacs with dead neutrophils, eosinophils, and fluid, making the patient struggle to breathe.  In addition to the inflammatory reaction, when these cells die they release digestive enzymes that can do terrible damage to the lungs or other infected tissues. The use of steroids to inhibit inflammation was a critical early discovery. According to a review I read recently, it is still the best early intervention. Most viruses have means to inhibit a host’s immune system:  some inhibit interferon synthesis, a critical mobilizer of the immune response; SARS-CoV-2 inhibits the production of Natural Killer cells, which recognize infected lung cells and kill them. The more we know about these mechanisms the better off we will be.

There are currently 23 antivirals approved or in testing, including Merck’s Molnupiravir and Pfizer’s Paxlovid, but others have Emergency Use Authorizations as well. Paxlovid, if taken within 5 days of the onset of symptoms, blocks disease progression and keeps 90% of patients from hospitalization.  As a result, our hospitals are able to function, saving money, reducing misery and increasing morale.  Vaccinated and boosted people usually have a short illness unless they have other complications and may not need these therapeutics. But for those who do, or are unvaccinated the drugs are becoming available in pharmacies.

My friend, Jonathan Sanoff, keeps track of these things. He told me about a site called the Therapeutics Locator, which The Assistant Secretary for Preparedness and Response at The Department of Health and Human Services and her staff have prepared. The Assistant Secretary is Rear Admiral Rachel L. Levine, MD. The site tells potential patients where to find these drugs, whether they are in Puerto Rico or Alaska. For skeptics, the site also includes the number of doses on hand at each site and the total made so far, as well as information on each drug. As new therapies come online, they will appear on the Therapeutics Locator. There are currently seven drugs and monoclonal antibodies on the site. The Asst Secretary and her staff do not get much credit, but they should. See: www.covid-19-therapeutics-locator-dhhs.hub.arcgis.com/.

It is important to have many anti-viral drugs, and I was surprised to learn that 23 are still in late clinicals trials. We learned from HIV therapy that an RNA virus can develop resistance to a single drug but cannot evolve resistance to three drugs and is why the number 23 is a pleasant surprise. An even better surprise is, some of these drugs inhibit other RNA viruses, including Zika and Ebola.

Nothing in science or medicine must work, no matter how clever the idea. We should not be surprised that 26 vaccines failed, 92 treatments did not pass muster, and 54 antivirals did not inhibit SARS-CoV-2.  These results on therapies in the development pipeline have been collected by Heidi Ledford, one of Nature Magazine’s senior reporters (Nature, March 3, 2022). I am grateful to her. In that context, the March 11 issue of Science, the flagship publication of the American Academy of Sciences, contains a detailed comparison and analysis of these treatments and ideas on what we need to prepare for the next epidemic. Pandemics are too large a subject to cover everything — we have left out the value of logistics and convincing people to take vaccines, not to mention long Covid, but people are studying these challenges. The combination of basic science, private industry, and public health services have done well, although praise sounds hollow when millions have died.

What to do? Get vaccinated and boosted. When new boosters designed to attack SARS-CoV-2 or its variants appear, get those too. Even with the vaccine, you may get mild disease, but the name of the game is to prevent progress to serious disease and hospitalization. The new drugs offer reassurance. In places where the virus and infection are in decline, it is time to resume normal life.  Or at least that is my plan.

 

Richard Kessin is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center. Reach him at Richard.Kessin@gmail.com. His website contains more information: RichardKessin.com.

 

 

       

             

 

Latest News

Luigina A. Dzenutis

CANTON — Luigina A. Dzenutis, 91, of Canton, died peacefully on Jan. 16, 2025, in her home. She was the wife of the late Peter A. Dzenutis Sr.

Luigina was born in Bronx, New York, on May 17, 1933, the daughter of the late Jack and Medie (Tonelli) Grecco.

Keep ReadingShow less
Donald Francis ‘Frank’ McNally

MILLERTON — Donald Francis “Frank” McNally Jr., passed away peacefully at Vassar Brothers Medical Center on Wednesday Jan. 8, 2025, after a short illness. Frank was a resident of Millerton since 1996. He was born on Jan. 27, 1955, in Cold Spring, New York, at Butterfield Hospital and was raised in Garrison, New York, where he enjoyed exploring and camping in the wilderness of the Hudson Valley, participating in the Boy Scouts as a bugler, and competing as captain of his high school wrestling team.

He was a graduate of James I. O’Neill High School in Highland Falls class of ‘74 and SUNY Cobleskill class of ‘76 where he majored in animal husbandry, specializing in equine science. He then proudly volunteered for the United States Peace Corps where he accepted an assignment to his host country of the Philippines, where he met his wife. Frank would then pursue his lifelong passion for horses and horseback riding on several horse farms in Dutchess County. Later he would work for New York state where he would then retire, spending his time caring for animals, reading, fishing and taking photographs. Frank enjoyed a good laugh with family and friends, while also occasionally winning a game of RISK. Frank was an avid reader, often reading several books a week while in the constant company of his cat.

Keep ReadingShow less
Florence Eugenia Cooper

NORFOLK — Florence Eugenia Cooper died on Sunday, Dec. 15, 2024, at the age of 92 at Geer Lodge in Canaan, Connecticut where she had been a resident for 2 ½ years. She also spent a couple of days a week at the home of her daughter, the artist Hilary Cooper and her husband Chris Crowley, in Lakeville.

Florence (neé Muhas) was born and grew up in Brooklyn, New York, the daughter of Greek immigrants. She went to local public schools and then to college at Barnard where she was mentored by Professor of Religion Ursula Niebuhr, wife of the philosopher Reinhold Niebuhr, who urged her to go to her alma mater St Hugh’s College, Oxford University where she earned a D. Phil degree. Later, she received an M.A. in foreign policy with a specialty in China, at the London School of Economics.

Keep ReadingShow less
Frederick Ralph Scoville II

WEST CORNWALL — Frederick Ralph Scoville II, 72, of 243 Town St., died Jan. 7, 2025, at the Waterbury Hospital surrounded by his loving family. Fred was the husband of 45 years to Lynn (Pollard) Scoville. Fred was born in Torrington, son of the late Ralph and Thalia (Hicock) Scoville.

Fred spent his whole life in West Cornwall. He attended Cornwall Consolidated and Housatonic Valley Regional High School. The only time he left was to attend the University of Connecticut for animal science. After school he came home to work with his father on the family farm taking over full-time in 1996 milking dairy cattle and selling hay. His life passion was the farm. He could always be found tinkering on equipment or surveying the neighborhood on his golf cart. The only thing that rivaled the farm was his love of his family. His wife, sons, daughter-in-law, and grandchildren meant the world to Fred.

Keep ReadingShow less